At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Get ready for a hefty hike in your Medicare Part B premiums. Learn how the 2025 increase will affect your budget and what ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain cancer.

This evidence supports the potential of microbiome-altering therapies to modulate the immune response and reduce the need for ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

Currently, the standard monthly Medicare Part B premium is $174.70. In 2025, it's rising to $185. That's an increase of ...

Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.

The death of Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, was caused by an ...

Our drug, tegoprubart, was discovered at the ALS Therapy Development ... “[Transplant patients] have to take an ...

"Full House" star Dave Coulier, 65, has been diagnosed with stage 3 non-Hodgkin lymphoma, the actor revealed in an exclusive ...